Related references
Note: Only part of the references are listed.Alzheimer's Disease and the Amyloid-β Peptide
M. Paul Murphy et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Current standard treatment of adult acute promyelocytic leukaemia
Francesco Lo-Coco et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia
Michelle L. Churchman et al.
CANCER CELL (2015)
Decrease in Hamilton Rating Scale for Depression Following Isotretinoin Therapy in Acne: An Open-Label Prospective Study
Pushpa Gnanaraj et al.
INDIAN JOURNAL OF DERMATOLOGY (2015)
Pretransplant comorbidities predict severity of acute graft-versus-host disease and subsequent mortality
Mohamed L. Sorror et al.
BLOOD (2014)
Unlocking the potential of retinoic acid in anticancer therapy
T. Schenk et al.
BRITISH JOURNAL OF CANCER (2014)
Retinoic Acid Actions through Mammalian Nuclear Receptors
Pengxiang Huang et al.
CHEMICAL REVIEWS (2014)
Retinoids as potential targets for Alzheimer's disease
Rupinder K. Sodhi et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide
Xiao-Han Tang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Association between isotretinoin and mood changes: Myth or reality? An updated overview
Angelo Massimiliano D'Erme et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2013)
Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion
T. Adhikary et al.
ONCOGENE (2013)
Analysis, occurrence, and function of 9-cis-retinoic acid
Maureen A. Kane
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Retinoids for treatment of Alzheimer's disease
Alan J. Lerner et al.
BIOFACTORS (2012)
Hypoxia-Inducible Factors in Physiology and Medicine
Gregg L. Semenza
CELL (2012)
Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies
Yong Wook Jung et al.
CURRENT OPINION IN NEUROLOGY (2012)
Combination of Pan-Histone Deacetylase Inhibitor and Autophagy Inhibitor Exerts Superior Efficacy against Triple-Negative Human Breast Cancer Cells
Rekha Rao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Regulation of alpha-secretase ADAM10 expression and activity
Kristina Endres et al.
EXPERIMENTAL BRAIN RESEARCH (2012)
The molecular physiology of nuclear retinoic acid receptors. From health to disease
Vanessa Duong et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Bexarotene Plus Erlotinib Suppress Lung Carcinogenesis Independent of KRAS Mutations in Two Clinical Trials and Transgenic Models
Konstantin H. Dragnev et al.
CANCER PREVENTION RESEARCH (2011)
Retinoic acid receptor modulators: a perspective on recent advances and promises
Susana Alvarez et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2011)
Essential Role for Retinoic Acid in the Promotion of CD4+ T Cell Effector Responses via Retinoic Acid Receptor Alpha
Jason A. Hall et al.
IMMUNITY (2011)
Inflammatory Back Pain in Patients Treated with Isotretinoin
Yavuz Pehlivan et al.
JOURNAL OF RHEUMATOLOGY (2011)
Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1
Wei Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Sven Trelle et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Variability Among Nonsteroidal Antiinflammatory Drugs in Risk of Upper Gastrointestinal Bleeding
Elvira L. Masso Gonzalez et al.
ARTHRITIS AND RHEUMATISM (2010)
The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS)
N. Fortunati et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology
A. D. Ormerod et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Oncogenic Potential of Retinoic Acid Receptor-γ in Hepatocellular Carcinoma
Ting-Dong Yan et al.
CANCER RESEARCH (2010)
A unique secondary-structure switch controls constitutive gene repression by retinoic acid receptor
Albane le Maire et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population
Marta L. Capone et al.
PHARMACOLOGICAL REPORTS (2010)
The Liver as a Lymphoid Organ
Ian Nicholas Crispe
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Ligands for Retinoic Acid Receptors Are Elevated in Osteoarthritis and May Contribute to Pathologic Processes in the Osteoarthritic Joint
Mark R. Davies et al.
ARTHRITIS AND RHEUMATISM (2009)
RARα2 expression is associated with disease progression and plays a crucial role in efficacy of ATRA treatment in myeloma
Siqing Wang et al.
BLOOD (2009)
Differential Action on Coregulator Interaction Defines Inverse Retinoid Agonists and Neutral Antagonists
Pierre Germain et al.
CHEMISTRY & BIOLOGY (2009)
A coordinated phosphorylation cascade initiated by p38MAPK/MSK1 directs RARα to target promoters
Nathalie Bruck et al.
EMBO JOURNAL (2009)
Regulation of secretases by all-trans-retinoic acid
Anna Koryakina et al.
FEBS JOURNAL (2009)
Retinoic acid syndrome: a review
E. Patatanian et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Isotretinoin and the risk of depression in patients with acne vulgaris:: A case-crossover study
Laurent Azoulay et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
Distinct Functions of Retinoic Acid Receptor Beta Isoforms: Implications for Targeted Therapy
Catherine Swift et al.
Endocrine Metabolic & Immune Disorders-Drug Targets (2008)
Solid lipid nanoparticles (SLN) of tretinoin: Potential in topical delivery
Kumar A. Shah et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Loss of Trim24 (Tif1α) gene function confers oncogenic activity to retinoic acid receptor alpha
Konstantin Khetchoumian et al.
NATURE GENETICS (2007)
Tumor-suppressive activity of retinoic acid receptor-β in cancer
Xiao-Chun Xu
CANCER LETTERS (2007)
Bexarotene-induced hypothyroidism: Bexarotene stimulates the peripheral metabolism of thyroid hormones
Johannes W. A. Smit et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
Antinociceptive and antiedematogenic activities of fenofibrate, an agonist of PPAR alpha, and pioglitazone, an agonist of PPAR gamma
Antonio Carlos P. Oliveira et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
A proof-of-principle clinical trial of bexarotene in patients with non-small cell lung cancer
Konstantin H. Dragnev et al.
CLINICAL CANCER RESEARCH (2007)
Structure, function and modulation of retinoic acid receptor beta, a tumor suppressor
Susana Alvarez et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
The optimal use of bexarotene in cutaneous T-cell lymphoma
R. Gniadecki et al.
BRITISH JOURNAL OF DERMATOLOGY (2007)
International Union of Pharmacology. LXIII. Retinoid X receptors
Pierre Germain et al.
PHARMACOLOGICAL REVIEWS (2006)
Review article: alcoholic liver disease - pathophysiological aspects and risk factors
A. Gramenzi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
RARγ is critical for maintaining a balance between hematopoietic stem cell self-renewal and differentiation
Louise E. Purton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Aberrant expression of β- and γ-catenin is an independent prognostic marker in oral squamous cell carcinoma
G Ueda et al.
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2006)
A novel retinoic acid receptor β isoform and retinoid resistance in lung carcinogenesis
WJ Petty et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Treatment concepts of acute promyelocytic leukemia
E Lengfelder et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Serum levels of albumin, triglycerides, total protein and glucose in rats are altered after oral treatment with low doses of 13-cis-retinoic acid or all-trans-retinoic acid
FJ Cisneros et al.
JOURNAL OF APPLIED TOXICOLOGY (2005)
Role of retinoid signalling in the adult brain
MA Lane et al.
PROGRESS IN NEUROBIOLOGY (2005)
Hypermethylation of the retinoic acid receptor-β2 gene in head and neck carcinogenesis
EM Youssef et al.
CLINICAL CANCER RESEARCH (2004)
Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL
N Clarke et al.
EMBO JOURNAL (2004)
Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis
CS Lieber
ALCOHOL (2004)
RARγ acts as a tumor suppressor in mouse keratinocytes
CF Chen et al.
ONCOGENE (2004)
Methylation and regulation of expression of different retinoic acid receptor beta isoforms in human colon cancer
EM Youssef et al.
CANCER BIOLOGY & THERAPY (2004)
Short-term administration of isotretinoin elevates plasma triglyceride concentrations without affecting insulin sensitivity in healthy humans
D Stoll et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Retinoic acid receptors and cancers
DR Soprano et al.
ANNUAL REVIEW OF NUTRITION (2004)
Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β/δ
N Shaw et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Retinoids in cancer therapy and chemoprevention: promise meets resistance
SJ Freemantle et al.
ONCOGENE (2003)
Hematopoiesis and retinoids: Development and disease
T Oren et al.
LEUKEMIA & LYMPHOMA (2003)
Evidence for defective retinoid transport and function in late onset Alzheimer's disease
AB Goodman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Retinoic acid receptors β and γ do not repress, but instead activate target gene transcription in both the absence and presence of hormone ligand
H Hauksdottir et al.
MOLECULAR ENDOCRINOLOGY (2003)
Selective retinoids and rexinoids in cancer therapy and chemoprevention
FC Zusi et al.
DRUG DISCOVERY TODAY (2002)
Downstream Codons in the retinoic acid receptor β-2 and β-4 mRNAs initiate translation of a protein isoform that disrupts retinoid-activated transcription
LI Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Methylation and silencing of the retinoic acid receptor-β2 gene in cervical cancer -: art. no. 4
T Ivanova et al.
BMC CANCER (2002)
Retinoids and their receptors in cancer development and chemoprevention
SY Sun et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2002)
Critical roles of PPARβ/δ in keratinocyte response to inflammation
NS Tan et al.
GENES & DEVELOPMENT (2001)
The promise of retinoids to fight against cancer
L Altucci et al.
NATURE REVIEWS CANCER (2001)
Lineage restriction of the RARα gene expression in myeloid differentiation
J Zhu et al.
BLOOD (2001)
Pathogenesis, diagnosis, and treatment of alcoholic liver disease
KVN Menon et al.
MAYO CLINIC PROCEEDINGS (2001)
The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers
T Nakayama et al.
LABORATORY INVESTIGATION (2001)
Retinoic acid-induced apoptosis in leukemia cells is mediated by paracrine action of tumor-selective death ligand TRAIL
L Altucci et al.
NATURE MEDICINE (2001)
Positive and negative regulation of granulopoiesis by endogenous RARα
P Kastner et al.
BLOOD (2001)
Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor β(δ)
JM Peters et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Methylation and silencing of the retinoic acid receptor-β2 gene in breast cancer
M Widschwendter et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Topical liposomal gel of tretinoin for the treatment of acne: Research and clinical implications
VB Patel et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2000)
Share Paper
